These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 18593370)

  • 1. Effective radiotherapy of primary tumors and metastasis with 18F-2-deoxy-2-fluoro-D-glucose in C57BL/6 mice.
    Caridad V; Arsenak M; Abad MJ; Martín R; Guillén N; Colmenter LF; Taylor P
    Cancer Biother Radiopharm; 2008 Jun; 23(3):371-5. PubMed ID: 18593370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Positron emission tomography agent 2-deoxy-2-[18F]fluoro-D-glucose has a therapeutic potential in breast cancer.
    Moadel RM; Nguyen AV; Lin EY; Lu P; Mani J; Blaufox MD; Pollard JW; Dadachova E
    Breast Cancer Res; 2003; 5(6):R199-205. PubMed ID: 14580255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microimaging characterization of a B16-F10 melanoma metastasis mouse model.
    Winkelmann CT; Figueroa SD; Rold TL; Volkert WA; Hoffman TJ
    Mol Imaging; 2006; 5(2):105-14. PubMed ID: 16954024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor viability evaluation by positron emission tomography with [18F]FDG in the liver metastasis rat model.
    Ishiwata K; Liu HY; Teramoto K; Kawamura K; Oda K; Arii S
    Ann Nucl Med; 2006 Aug; 20(7):463-9. PubMed ID: 17037278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and preclinical evaluation of a folic acid derivative labeled with 18F for PET imaging of folate receptor-positive tumors.
    Bettio A; Honer M; Müller C; Brühlmeier M; Müller U; Schibli R; Groehn V; Schubiger AP; Ametamey SM
    J Nucl Med; 2006 Jul; 47(7):1153-60. PubMed ID: 16818950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility of 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography and positron emission tomography/computed tomography imaging in the preoperative staging of head and neck squamous cell carcinoma.
    Roh JL; Yeo NK; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
    Oral Oncol; 2007 Oct; 43(9):887-93. PubMed ID: 17207656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility of positron emission tomography in sarcomas.
    Schuetze SM
    Curr Opin Oncol; 2006 Jul; 18(4):369-73. PubMed ID: 16721133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monitoring Mitochondrial Complex-I Activity Using Novel PET Probe 18F-BCPP-EF Allows Early Detection of Radiotherapy Effect in Murine Squamous Cell Carcinoma.
    Murayama C; Kawaguchi AT; Kamijo A; Naito K; Kanazawa M; Tsukada H
    PLoS One; 2017; 12(1):e0170911. PubMed ID: 28125711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Practical integration of [18F]-FDG-PET and PET-CT in the planning of radiotherapy for non-small cell lung cancer (NSCLC): the technical basis, ICRU-target volumes, problems, perspectives.
    Nestle U; Kremp S; Grosu AL
    Radiother Oncol; 2006 Nov; 81(2):209-25. PubMed ID: 17064802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2-[18F]-2-deoxy-D-glucose (FDG) uptake in human tumor cells is related to the expression of GLUT-1 and hexokinase II.
    Ong LC; Jin Y; Song IC; Yu S; Zhang K; Chow PK
    Acta Radiol; 2008 Dec; 49(10):1145-53. PubMed ID: 18979289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of diethylnitrosamine- or hepatitis B virus X gene-induced hepatocellular carcinoma with 18F-FDG PET/CT: a preclinical study.
    Park JH; Kang JH; Lee YJ; Kim KI; Lee TS; Kim KM; Park JA; Ko YO; Yu DY; Nahm SS; Jeon TJ; Park YS; Lim SM
    Oncol Rep; 2015 Jan; 33(1):347-53. PubMed ID: 25371060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longitudinal evaluation of tumor metastasis by an FDG-microPet/microCT dual-imaging modality in a lung carcinoma-bearing mouse model.
    Chang CH; Jan ML; Fan KH; Wang HE; Tsai TH; Chen CF; Fu YK; Lee TW
    Anticancer Res; 2006; 26(1A):159-66. PubMed ID: 16475693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Inhibition of 18F-FDG uptake in glioblastoma cells by FDG and glucose].
    Oehr P; Ruhlmann J; Kozak B; Brock H; Thieme D; Rink H
    Acta Med Austriaca; 1999; 26(3):101-3. PubMed ID: 10520378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of mitomycin C and vinblastine on FDG uptake of human nonsmall-cell lung cancer xenografts in nude mice.
    Tian M; Zhang H; Higuchi T; Oriuchi N; Inoue T; Endo K
    Cancer Biother Radiopharm; 2004 Oct; 19(5):601-5. PubMed ID: 15650452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biological significance of 18F-FDG uptake on PET in patients with non-small-cell lung cancer.
    Kaira K; Serizawa M; Koh Y; Takahashi T; Yamaguchi A; Hanaoka H; Oriuchi N; Endo M; Ohde Y; Nakajima T; Yamamoto N
    Lung Cancer; 2014 Feb; 83(2):197-204. PubMed ID: 24365102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preclinical and clinical evidence that Deoxy-2-[18F]fluoro-D-glucose positron emission tomography with computed tomography is a reliable tool for the detection of early molecular responses to erlotinib in head and neck cancer.
    Vergez S; Delord JP; Thomas F; Rochaix P; Caselles O; Filleron T; Brillouet S; Canal P; Courbon F; Allal BC
    Clin Cancer Res; 2010 Sep; 16(17):4434-45. PubMed ID: 20660574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [18F]FDG-PET-Based Personalized Radiotherapy Dose Prescription.
    Kaanders JHAM; Bussink J; Aarntzen EHJG; Braam P; Rütten H; van der Maazen RWM; Verheij M; van den Bosch S
    Semin Radiat Oncol; 2023 Jul; 33(3):287-297. PubMed ID: 37331783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Virtual 18F-FDG PET/CT bronchoscopy for lymph node staging in non-small-cell lung cancer patients: present and future applications.
    Buchbender C; Herbrik M; Treffert J; Forsting M; Bockisch A; Antoch G; Heusner TA
    Expert Rev Med Devices; 2012 May; 9(3):241-7. PubMed ID: 22702254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparative analysis of the informative value of 18F-fluorodeoxyglucose and 11C-methionine positron emission tomography in the differential diagnosis of solitary lung masses].
    Tlostanova MS; Avetisian AO; Kozak AR
    Vestn Rentgenol Radiol; 2014; (3):13-9. PubMed ID: 25782293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Positron emitting 18F-2-deoxy-2-fluoro-D-glucose: potential hot new therapy.
    Mortimer JE; Taylor ME
    Breast Cancer Res; 2003; 5(6):329-31. PubMed ID: 14580251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.